Vitamin D and chronic kidney disease

Ethnicity and Disease

Volumn 19, Issue 4 SUPPL.5, 2009, Pages

  Williams, Sandra ^a   Malatesta, Karla ^a   Norris, Keith ^a,b  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiovascular; Chronic kidney disease; Vitamin D

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; CALCITRIOL; COLECALCIFEROL; ERGOCALCIFEROL; VITAMIN D; VITAMIN D RECEPTOR;

AUTOCRINE EFFECT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CELL DIFFERENTIATION; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; HEALTH DISPARITY; HIGH RISK PATIENT; HUMAN; IMMUNE SYSTEM; KIDNEY FAILURE; NONHUMAN; PRACTICE GUIDELINE; RECOMMENDED DRUG DOSE; RENAL SYSTEM PARAMETERS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 80053196802     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. 3. Seminars in Dialysis. 2007;20(4):316-324.
2. Heaney RP. Vitamin D in health and disease. Clin J Am Soc Nephrol. 2008;3(5):1535-1541.
3. Li YC. Renoprotective effects of vitamin D analogs. Kidney Int. 2009;May 27 [Epub ahead of print].
4. Al-Badr W, Martin KJ. Vitamin D and kidney disease. Clin J Am Soc Nephrol. 2008;3(5):1555-1560.
5. Mehrotra R, Kermah D, Salusky I, Wolf M, Thadhani R, Chiu YW, Martins D, Adler S, Norris K. Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int. 2009;Aug 5 [Epub ahead of print].
6. Cheng S, Coyne D. Vitamin D and outcomes in chronic kidney disease. Curr Opin Nephrol Hypertens. 2007;16(2):77-82.
7. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266-281.
8. Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008;29:726-776.
9. Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev. 2005;26:662-687. (Pubitemid 41127276)
10. Rostand SG, Warnock DG. Introduction to vitamin D symposium, March 14, 2008. Clin J Am Soc Nephrol. 2008;3(5):1534.
11. Zhang Z, Sun L, Wang Y, et al. Renoprotective role of the vitamin D receptor in diabetic nephropathy. Kidney Int. 2008;73:163-171.
12. Carey RM, Siragy HM. The intrarenal renin-angiotensin system and diabetic nephropathy. Trends Endocrinol Metab. 2003;14:274-281. (Pubitemid 36992197)
13. Zhang Z, Zhang Y, Ning G, Deb DK, Kong J, Li YC. Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase. Proc Natl Acad Sci U S A. 2008;105(41):15896-15901.
14. Alborzi P, Patel NA, Peterson C, Bills JE, Bekele DM, Bunaye Z, Light RP, Agarwal R. Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial. Hypertension. 2008;52(2):249-255.
15. De Boer IH, Ioannou GN, Kestenbaum B, et al. 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis. 2007;50:69-77. (Pubitemid 46962855)
16. Artaza JN, Mehrotra R, Norris KC. Vitamin D and the cardiovascular system. Clin J Am Soc Nephrol. 2009;4:1515-1522.
17. 3 targeting of NF-kappa B suppresses high glucose-induced MCP-1 expression in mesangial cells. Kidney Int. 2007;72(2):193-201.